Company
MFX
Accelerating Cell and Gene Therapy Development & Manufacturing
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- mfx.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 18 September 2026
About
MFX is developing the Cyto Engine™ to unblock this access. Accelerating development and powering manufacturing by combining scalable, automated bioprocessing with powerful analytics and data.
Products
- Hardware
- Cyto Engine
Loading relationship preview